Should endocrine therapy still be used as an initial treatment for postmenopausal women with metastatic breast cancer?

被引：0
|
作者：
Orlando, Laura [1 ,2 ]
Cinieri, Saverio [1 ,2 ]
机构：
[1] Antonio Perrino Hosp, Med Oncol Div, Brindisi, Italy
[2] Antonio Perrino Hosp, Breast Unit, Brindisi, Italy
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 16期
关键词：
endocrine-positive breast cancer; endocrine resistance; EVEROLIMUS PLUS EXEMESTANE; FULVESTRANT; 500; MG; GROWTH-FACTOR; PALBOCICLIB; INHIBITOR; LETROZOLE;
D O I：
10.2217/fon-2017-0101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1361 / 1364
页数：4
相关论文
共 50 条
  • [31] Endocrine treatment of metastatic breast cancer
    Polasik, Arkadius
    Huober, Jens
    Janni, Wolfgang
    Huesmann, Sophia
    GYNAKOLOGE, 2019, 52 (04): : 295 - 304
  • [32] Endocrine treatment of metastatic breast cancer
    Gerber, Bernd
    Huober, Jens
    BREAST CARE, 2006, 1 (04) : 248 - 251
  • [33] Endocrine treatment of metastatic breast cancer
    Polasik, Arkadius
    Huober, Jens
    Janni, Wolfgang
    Huesmann, Sophia
    ONKOLOGE, 2019, 25 (05): : 469 - 478
  • [34] ENDOCRINE TREATMENT OF METASTATIC BREAST CANCER
    HORTLING, H
    GERIATRICS, 1965, 20 (01) : 51 - &
  • [35] The endocrine management of postmenopausal women with early breast cancer
    Michael Baum
    Breast Cancer, 2004, 11 (1) : 15 - 19
  • [36] Sequential second line endocrine therapy is still an effective strategy for postmenopausal ER+ and HER2-advanced breast cancer with low sensitivity to initial endocrine therapy
    Araki, K.
    Fujisawa, T.
    Sakamaki, K.
    Kikawa, Y.
    Iwamoto, T.
    Sangai, T.
    Shien, T.
    Takao, S.
    Nishimura, R.
    Takahashi, M.
    Aihara, T.
    Mukai, H.
    Taira, N.
    CANCER RESEARCH, 2019, 79 (04)
  • [37] Comparing guidelines for adjuvant endocrine therapy in postmenopausal women with breast cancer: a coming of age
    Verma, Sunil
    Jackisch, Christian
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (02) : 277 - 286
  • [38] Adjuvant endocrine therapy in postmenopausal women with early breast cancer: Where are we now?
    Baum, M
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (12) : 1667 - 1677
  • [39] Potential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancer
    Taichman, L. Susan
    Havens, Aaron M.
    Van Poznak, Catherine H.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 23 - 32
  • [40] The prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer
    Chin, S. N.
    Trinkaus, M. E.
    Simmons, C.
    Flynn, C.
    Bolivar, R.
    Clemons, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345